ACE and diabetic kidney disease: Although further study is needed to explore the change in metabolism caused by ACE inhibitors or other angiotensin receptor blockers, our findings demonstrate that metabolomic analysis may help to elucidate the DKD-related pathological processes and to discover a new therapeutic agent for DKD.